Rosetta Genomics (ROSG) is On the Move
Tweet Send to a Friend
Up)
Despite disclosing an equity offering after the close, Rosetta Genomics, Ltd. (Nasdaq: ROSG) is riding the momentum train higher again.
In addition to announcing New York state approval for miRview lung, traders are talking about a 'short squeeze.'
Shares of ROSG last traded at $13.14, up 11.8 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
In addition to announcing New York state approval for miRview lung, traders are talking about a 'short squeeze.'
Shares of ROSG last traded at $13.14, up 11.8 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Tesla (TSLA) Ramps Higher (GM)
- Merck (MRK) Oct. Call Options See Massive Volume Spike
- Biodel (BIOD) Lifts Following Pump Article
Create E-mail Alert Related Categories
Momentum Movers, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
